共 37 条
- [1] Rüegg C(2010)Vascular integrins: therapeutic and imaging targets of tumor angiogenesis Recent Results Cancer Res 180 83-101
- [2] Alghisi GC(2014)Integrins: players in cancer progression and targets in cancer therapy Anticancer Drugs 25 1107-21
- [3] Sun C-C(2004)Integrins: roles in cancer development and as treatment targets Br J Cancer 90 561-5
- [4] Qu X-J(2011)Phase I study of E7820, an oral inhibitor of integrin α-2 expression with antiangiogenic properties, in patients with advanced malignancies Clin Cancer Res 17 193-200
- [5] Gao Z-H(2014)Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours Invest New Drugs 32 481-488
- [6] Jin H(2014)A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy Eur Urol 65 897-904
- [7] Varner J(2006)Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours Br J Cancer 94 1621-6
- [8] Mita M(2011)A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma Br J Cancer 105 346-52
- [9] Kelly KR(2013)Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer Ann Oncol 24 90-6
- [10] Mita A(2010)Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma J Clin Oncol 28 2712-2718